For the trial, researchers
enrolled 120 children from 2 to 18 years old with Dravet syndrome, a rare genetic form of
epilepsy that kills up to 20 percent of
patients by the time they are 20.
26
patients were
enrolled in the study but did not complete MRI scanning for reasons including positive urinalysis, not meeting substance use disorder screening criteria, IQ < 80, MRI contraindications,
epilepsy, positive pregnancy test, court - ordered ankle monitor that could not be removed, or simply no longer willing to participate.